Abstract:Objective To investigate the effect of exendin-4, a glucagon-like peptide-1 ( GLP-1) receptor agonist , on reducing lipid deposition and improving insulin resistance in skeletal muscle and the underlying mechanisms in high-fat diet ( HFD)-induced obese mice.Methods Twelve male C57BL/6J mice were challenged with HFD for 12 weeks to induce obesity and then randomly divided into two groups:exendin-4 group (intraperitoneal injection of 24 nmol· kg-1 · d-1 exendin-4 for 4 weeks) and HFD group (intraperitoneal injection of normal saline for 4 weeks), with 6 mice in each group.Additional 6 mice were also selected as control group.Body weight , fasting blood glucose were recorded .Serum triglyceride ( TG) , total cholesterol ( TC ) , insulin and skeletal muscle triglyceride levels were measured by enzyme-linked immunosobent assay ( ELISA).Oil red O staining was used for morphologic changes of frozen sections from skeletal muscle.The protein levels of lipid metabolic pathway mediated by AMP-activated protein kinase ( AMPK) and insulin signailing pathway were determined by Western blot.Results Compared with mice in HFD group, exendin-4 significantly decreased body weight [(37.68 ±1.80) vs (46.03 ±5.00) g, P<0.025], fasting blood glucose[(5.40 ±0.33) vs (7.65 ±1.92) mmol/L, P<0.025], serum TG[(37.78 ± 7.14) vs (80.76 ±34.22) mg/dl, P<0.025], TC[(180.13 ±18.75) vs (217.57 ±22.52) mg/dl, P<0.025], insulin [(0.58 ±0.01) vs (1.67 ±1.23) ng/ml, P<0.025] and skeletal muscle TG levels [(9.84 ±1.08) vs (19.35 ±7.44) mg/g, P<0.025] of obese mice.Oil red O staining revealed that exendin-4 alleviated the accumulation of larger lipid droplets in skeletal muscle.The protein expressions of lipolysis and lipid oxidation mediated by AMPK and insulin signailing pathway were up -regulated, and the protein expressions of lipogenesis mediated by AMPK were down-regulated after intervention of exendin-4. Conclusion Exendin-4 reduces lipid deposition and insulin resistance in skeletal muscle of HFD-induced obese mice via activating AMPK and up-regulating insulin signailing pathway.

Effect of GLP-1 receptor agonist on lipolysis in adipose tissue of obese mice and its underlying mechanism

Effect of Exendin-4 on Lipid Deposition in Skeletal Muscle of Diet-Induced Obese Mice and Its Underlying Mechanism

Exendin-4 Improves Fat Metabolism of Brown Adipose Tissue in High-Fat Diet-Induced Obese C57BL/6J Mice

GLP-1 Receptor Agonist Promotes Brown Remodelling in Mouse White Adipose Tissue Through SIRT1

Glucagon-like Peptide-1 Improves Fatty Liver and Enhances Thermogenesis in Brown Adipose Tissue via Inhibiting BMP4-Related Signaling Pathway in High-Fat-Diet-Induced Obese Mice

Exendin-4 Improves Thermogenic Capacity by Regulating Fat Metabolism on Brown Adipose Tissue in Mice with Diet-Induced Obesity

The Anorexic Effect of Ex4/Fc Through Glp-1 Receptor Activation in High-Fat Diet Fed Mice

Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice

[The Preliminary Investigation of GLP-1 Receptor Agonist on Liver Steatosis in Obese Mice].

PS16 - 82. GLP-1 Receptor Agonism Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High Fat Diet-Fed APOE*3-Leiden Mice

Effects and Mechanisms of GLP-1 on Fatty Acid Metabolism in Insulin-Resistant 3T3-L1 Adipocytes

The Effects of New Selective PPARα Agonist CP775146 on Systematic Lipid Metabolism in Obese Mice and Its Potential Mechanism.

EGLP-1 lowers body weight better than exendin-4 by reducing food intake and increasing basal energy expenditure in diet-induced obese mice

Effects of Exenatide on Lipid Metabolism of Adipose Tissue in Diabetic Rats

Glp-1 Receptor Activation Inhibits Vldl Production And Reverses Hepatic Steatosis By Decreasing Hepatic Lipogenesis In High-Fat-Fed Apoe*3-Leiden Mice

Sirt1 Mediates the Effect of Glp-1 Receptor Agonist Exenatide on Ameliorating Hepatic Steatosis

Diet-Induced Adipose Tissue Inflammation and Hypoxia Are Reversed by GLP-1 Potentially Via Improved Microcirculation

GLP-1 Amplifies Insulin Signaling by Up-Regulation of IRβ, IRS-1 and Glut4 in 3T3-L1 Adipocytes

Glucagon Like Peptide-1 Promotes Adipocyte Differentiation Via the Wnt4 Mediated Sequestering of Beta-Catenin

1938-P: GLP-1 Receptor Agonist Ameliorates Intramyocellular Lipid Deposition Without Weight Loss by Activating AMPK

Exenatide Mitigates Inflammation and Hypoxia along with Improved Angiogenesis in Obese Fat Tissue.